<DOC>
	<DOC>NCT00544895</DOC>
	<brief_summary>NEOBRAIN brings together small and medium sized enterprises (SMEs), industry and academic groups devoted to the diagnosis, management, and neuroprotection in newborns with perinatal brain damage. The focus of NEOBRAIN is to identify strategies prevention of brain damage mainly observed in preterm newborns. (Copy from www.neobrain.eu)</brief_summary>
	<brief_title>Neonatal Estimation Of Brain Damage Risk And Identification of Neuroprotectants</brief_title>
	<detailed_description />
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Brain Damage, Chronic</mesh_term>
	<mesh_term>Neuroprotective Agents</mesh_term>
	<criteria>Gestational age &lt; 28 weeks</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>